Unichem Pharmaceuticals USA Inc. recalls

All Unichem Pharmaceuticals USA Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (4).

4 recalls published between September 24, 2025 and May 13, 2026. Most common issues: potency (1), manufacturing practices (cgmp) (1). 1 was FDA Class I, the most serious level.

• busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only… recall
  FDA May 13, 2026 · Unichem Pharmaceuticals USA Inc. · Class III
• Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only… recall
  FDA February 18, 2026 · Unichem Pharmaceuticals USA Inc. · Class III
• Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg… recall
  FDA February 11, 2026 · Unichem Pharmaceuticals USA Inc. · Class II
• Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle… recall
  FDA September 24, 2025 · Unichem Pharmaceuticals USA Inc. · Class I